Holen Sie sich die Stockscreener-App
10.51
6.16%
-0.69
Handel nachbörslich:
10.00
-0.51
-4.85%
Schlusskurs vom Vortag:
$11.20
Offen:
$11.1
24-Stunden-Volumen:
34,209
Relative Volume:
0.25
Marktkapitalisierung:
$8.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.93M
KGV:
-0.0395
EPS:
-266.137
Netto-Cashflow:
$-15.87M
1W Leistung:
-20.02%
1M Leistung:
-0.52%
6M Leistung:
-26.72%
1J Leistung:
-97.63%
1-Tages-Spanne:
$10.51
$11.10
1-Wochen-Bereich:
$10.51
$13.21
52-Wochen-Spanne:
$6.1478
$504.97
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Firmenname
Transcode Therapeutics Inc
Sektor
Branche
Telefon
857-301-6857
Adresse
6 LIBERTY SQUARE, BOSTON
Vergleichen Sie RNAZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
10.51 | 10.27M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Transcode Therapeutics Inc Aktie (RNAZ) Neueste Nachrichten
Is TransCode Therapeutics Inc. stock resilient to inflationJuly 2025 Movers & High Yield Equity Trading Tips - newser.com
How TransCode Therapeutics Inc. stock reacts to job market dataMarket Sentiment Report & Real-Time Buy Signal Notifications - newser.com
Real time breakdown of TransCode Therapeutics Inc. stock performanceJuly 2025 Opening Moves & Weekly High Return Stock Forecasts - newser.com
What MACD and RSI say about TransCode Therapeutics Inc.Market Risk Analysis & Low Volatility Stock Suggestions - newser.com
Market reaction to TransCode Therapeutics Inc.’s recent newsJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Can TransCode Therapeutics Inc. stock deliver strong Q4 earningsJuly 2025 Intraday Action & Long-Term Investment Growth Plans - newser.com
What’s the recovery path for long term holders of TransCode Therapeutics Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Is TransCode Therapeutics Inc. stock oversold or undervaluedJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com
TransCode Therapeutics Inc. recovery potential after sell offMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
What to do if you’re stuck in TransCode Therapeutics Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Why TransCode Therapeutics Inc. stock could be next big winnerPortfolio Return Report & High Yield Equity Trading Tips - newser.com
Ranking BMRN among high performing stocks via toolsJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com
Using Bollinger Bands to evaluate TransCode Therapeutics Inc.Market Sentiment Review & Safe Capital Preservation Plans - newser.com
Why retail investors favor TransCode Therapeutics Inc. stockTrade Risk Assessment & Precise Trade Entry Recommendations - newser.com
Forecasting TransCode Therapeutics Inc. price range with options data2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - newser.com
How to manage a losing position in TransCode Therapeutics Inc.July 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
What technical models suggest about TransCode Therapeutics Inc.’s comebackJuly 2025 Sector Moves & Safe Entry Point Alerts - newser.com
Is a relief rally coming for TransCode Therapeutics Inc. holders2025 Biggest Moves & Precise Entry and Exit Recommendations - newser.com
Can swing trading help recover from TransCode Therapeutics Inc. losses2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com
Is TransCode Therapeutics Inc. stock attractive for growth ETFs2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com
Why TransCode Therapeutics Inc. stock is considered a top pickWeekly Stock Recap & AI Driven Price Predictions - newser.com
Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):